The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 27th 2025
GLP-1 receptor agonists show promise in improving survival rates for older cancer patients with type 2 diabetes (T2D), highlighting their potential in oncology.
Nonprescription Self-Management of Functional Dyspepsia
September 26th 2016Recently, there's been an uptick in studies and articles about functional dyspepsia (FD). The reason is probably that FD is quite common (10% to 15% of the US population has it), and many clinicians fail to differentiate FD from other gastrointestinal disturbances.
Read More
Dispensing Clean Needles to Injectable Drug Users
September 21st 2016The great debate of whether pharmacies should dispense clean needles and syringes to injectable drug users has resurfaced. Although some critics view it as pure evil, I find it purely necessary. When patients come in for the needles, I gladly sell them.
Read More
Type 2 Diabetes Treatment Invokamet XR Approved
September 21st 2016The FDA has just approved Janssen's Invokamet XR, a once-daily, fixed-dose combination of canagliflozin (Invokana) and extended-release metformin hydrochloride, for first-line treatment for type 2 diabetes in adults as an adjunct to diet and exercise.
Read More